A study to evaluate the immunogenicity, safety and reactogenicity of a second vaccination with the adjuvanted influenza vaccine candidate compared to Fluarix administered intramuscularly in elderly aged 60 years and above.

Trial Profile

A study to evaluate the immunogenicity, safety and reactogenicity of a second vaccination with the adjuvanted influenza vaccine candidate compared to Fluarix administered intramuscularly in elderly aged 60 years and above.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2016

At a glance

  • Drugs GSK 1247446A (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 19 Mar 2008 Status changed from in progress to completed, in accordance with clinicaltrials.gov.
    • 12 Jan 2007 Status change
    • 17 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top